Abstract
The role of triodothyronine (T3 in regulating thyroid function is paramount in that at cellular level it interacts with receptors in the nucleus and thereby modulates gene expression. The multiple steps in the processing of lodide by the thyroid gland is under the influence of the thyroid stimulating hormone (TSH). In terms of laboratory evaluation of thyroid function the primary test is TSH. To discriminate between hypothalamic and pitutary dysfunction, the thyroid releasing hormone (TRH) stimulation test is useful. Currently used 2-site Immunometric procedures that employ mouse monoclonal antibodies can be subject to Interference by heterophlle antibodies in patient's serum. Drugs and other extraneous substances can influence the results obtained in some thyroid function tests. Thyroid dysfunction could also be due to autoimmune disease. The limitations of the usefulness of thyroid function tests in non-thyroidal illness should be kept in perspective. In conclusion, the proper interpretation of results of thyroid function tests depends on the sound understanding of concepts of thyroid function and variables affecting laboratory testing.
Similar content being viewed by others
References
Brent, G.A. (1994) The molecular basis of thyroid homone action. New Engl. J. Med. 331, 847–853.
Brent, G.A., Moore, D.D. and Larsen, P.R. (1991) Thyroid homone regulation of gene expression. Ann. Rev. Physiol. 53, 17–35.
Ismai-Berg, F. (1992) Regulation of Na+, K+-ATPase application by thyroid hormone. Semin. Nephrol. 12, 44–48.
Burrow, G.N., Fleber, D.A. and Larsen, P.R. (1994) Multive fold thyroid function. New Engl. J. Med. 331, 1072–1078.
Dayen, C.M., Danish, G.H. (1996) Chronic autoimmune thyroids. New Engl. J. Med. 335, 99–107.
Giordano, C., Stassi, G., Dellaria, R. et al. (1997) Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275, 960–963.
Wood, L.C. and Ingbar, S.H. (1979) Hypothyroidism as a late sequela in patients with Graves' disease treated with antithyroid agents. J. Clin. Invest. 64, 1429–1436.
Trip, M.D., Wiersinga, W. and Plomp, T.A. (1991) Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. Am. J. Med. 91, 507–511.
Lazarus, J.H., Hohn, R., Bennie, E.H., Chalmers, R.J. and Crockett, G. (1981) Lithium therapy and thyroid function: a long term study. Psychol. Med. 11, 85–92.
Vanderpump, M.P.J., Tunbridge, W.M.G., French, J.M. et al. (1995) The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin. Endocrinol (Oxf). 43, 55–68.
Kato, I., Tajima, K., Suchi, T. et al. (1985) Chronic thyroiditis as a risk factor for B-cell lymphoma in the thyroid gland. Jpn. J. Cancer Res. 6, 1085–1090.
Tamaki, H., Amino, N., Aozasa, M. et al. (1989) Effective method of prediction of transient hypothyroidism in neonated born to mothers with chronic thyroiditis. Am. J. Perinatol. 6, 296–303.
Stagnaro-Green A. (1993) Postpartum thyroiditis: Prevalence, etiology and clinical implications. Thyroid Today 16, 1–11.
Othman, S., Phillips, D.I.W., Parkes, A.B. et al. (1990) A long-term follow-up of postpartum thyroiditis. Clin. Endocrinol (Oxf). 32, 559–64.
Gesundheit, N., Petrick, P.A., Nissim, M. et al. (1989) Thyrotropin-secreting pituitary adenomas: clinical and biochemical heterogeneity. Ann. Intern. Med. 1989; 111, 827–835.
Retetoff, S., Weiss, R.E. and Usala, S.J. (1993) The syndromes of resistance to thyroid hormone. Endocr. Rev. 14, 348–399.
Tsurata, E., Tada, H., Tamaki, H., et al. (1995) Pathogenic role of asialo human chorionic gonadotropin in gastational thyrotoxicosis. J. Clin. Endocrinol. Metab. 80, 350–355.
Devaney, K., Snyder, R., Norris, H.J. and Tavassoll, F.A. (1993) Proliferative and histologically malignant struma ovary: a clinicopathologic study of 54 cases. Int. J. Gynecol. Pathol. 12, 333–343.
Surks, M.I. and Ocampo, E. (1996) Subclinical thyroid disease. Am. J. Med. 100, 217–223.
Sawin, C.T., Geller, A., Wolf, P.A., et al. (1994) Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. New Engl. J. Med. 331, 1249–52.
Mariotti, S., Franceschi, C., Cossarizza, A. and Pinchera, A. (1995) The aging thyroid. Endocr. Rev. 16, 686–715.
Barutska, D.G., Bergman, D.A., Bray, G.A., et al. (1995) AACE clinical practice guidelines for the evaluation and treatment of hypothyroidism. American Association of Clinical Endocrinologists, Jacksonville, Florida.
Spencer, C.A., Takeuchi, M. and Kazarosyan, M. (1996) Current status and performance goals for serum thyrotropin (TSH) assays. Clin. Chem. 42, 140–145.
Toft, A.D. (1994) Thyroxine therapy. N. Engl. J. Med. 331, 174–180.
Braverman, L.E. (1996) Evaluation of thyroid status in patients with thyrotoxicosis. Clin. Chem. 42, 174–178.
Keffer, J.H. (1996) Preanalytical considerations in testing thyroid function. Clin. Chem. 42, 125–134.
Narayanan, S. (1995) Interpretation of laboratory data: problem solving using case histories. Proc. 7th Asian Pacific Congress of Clinical chemistry, 85–90. Bankok, Thailand.
Boscato, L.M. and Stuart, M.C. (1988) Heterophilic antibodies: a problem for all immunoassays. Clin. Chem. 34, 27–33.
Klee, G.G. and Hay, I.D. (1994) Biochemical thyroid function testing. Mayo. Clin. Proc. 69, 469–470.
Feldkamp, C.S. and Carey, J.L. (1996) An algorithmic approach to thyroid function testing in a managed care setting. 3-year experience. Am. J. Clin. Pathol. 105, 11–16.
Elkins, R. (1987) Validity of analog free thyroxin immunoassays. Clin. Chem. 33, 2137–52.
Nelson, J.G., Weiss, R.M., Wlicox, R.B. (1994) Underestimates of serum free thyroxin (T4) concentrations by free T4 immunoassays. J. Clin. Endocrinol. Metab. 79, 76–79.
Nelson, J.C. and Tomei, R.T. (1988) Dependence of the thyroxin/thyroxin-binding, globulin (TBG) ratio and the free thyroxin index on TBG concentrations. Clin. Chem. 35, 541–544.
Nelson, J.C. and Wicox, R.B. (1996) Analytical performance of free and total thyroxine assays. Clin. Chem. 42, 146–154.
Klee, G.G. (1996) Clinical usage recommendations and analytic performance goals for total and free triiodothyronine measurements. Clin. Chem. 42, 155–159.
Tajiri, J., Noguchi, S., Morita, M., et al. Serum free, triodothyronine to free thyroxine ratio enables early prediction of the outcome of antithyroid drug therapy in patients with Graves' hyperthyroidism. Endocrinol. Jpn. 38, 683–687.
Feldt-Rasmussen, U. (1996) Anlytcal and clinical performance goals for testing autoantibodies to thyroperoxidase, thyroglobulin, and thyrotropin receptor. Clin. Chem. 42, 160–163.
Ladenson, P.W. (1996) Optimal laboratory testing for diagnosis and monitoring of thyroid nodules, goiter, and thyroid cancer. Clin. Chem. 42, 183–187.
Guder, W.G., Narayanan, S., Wisser, H., Zawta, B. (1996) Samples: from the patient to the laboatory. The impact of preanalytical variables on the quality of laboratory results. Darmstadt, Germany, Git-Verlag, 1996.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Narayana, S. Current concepts of thyroid function and laboratory evaluation. Indian J Clin Biochem 12, 25–34 (1997). https://doi.org/10.1007/BF02867951
Issue Date:
DOI: https://doi.org/10.1007/BF02867951